Rami Komrokji, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rami Komrokji, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01822691 · Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)H. Lee Moffitt Cancer Center and Research Institute · completed · Myelodysplastic Syndromes · principal investigator
- Ph1NCT01286038 · Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With ThrombocytopeniaH. Lee Moffitt Cancer Center and Research Institute · terminated · Myelodysplastic Syndrome (MDS), Thrombocytopenia · principal investigator
- Ph2NCT01133275 · Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDSH. Lee Moffitt Cancer Center and Research Institute · completed · Myelodysplastic Syndrome, MDS · principal investigator
- Ph2NCT00977548 · Erlotinib Study for Myelodysplastic Syndrome (MDS)H. Lee Moffitt Cancer Center and Research Institute · completed · Myelodysplastic Syndrome · principal investigator
- Ph2NCT00955916 · CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)H. Lee Moffitt Cancer Center and Research Institute · completed · Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.